phosphotyrosine has been researched along with pd 173955 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdullah, OM; Bohacek, RS; Clackson, T; Dalgarno, D; Deininger, MW; Druker, BJ; Keats, JA; Metcalf, CA; Moseson, EM; O'Hare, T; Pollock, R; Rivera, VM; Sawyer, TK; Shakespeare, WC; Stoffregen, EP; Sundaramoorthi, R; Tang, H; Wang, Y | 1 |
1 other study(ies) available for phosphotyrosine and pd 173955
Article | Year |
---|---|
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Amino Acids; Apoptosis; Benzamides; Cell Cycle; Cell Division; DNA-Binding Proteins; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Imatinib Mesylate; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Milk Proteins; Models, Molecular; Mutation; Nuclear Proteins; Phosphorylation; Phosphotyrosine; Piperazines; Protein Structure, Tertiary; Pyridones; Pyrimidines; STAT5 Transcription Factor; Trans-Activators | 2004 |